搜尋
Nuvation Bio Inc
NUVB添加自選
6.265USD
-0.065-1.03%
交易中 （美東）報價延遲15分鐘
2.17B總市值
虧損本益比TTM
股東統計
更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Hung (David T)
17.02%
Fidelity Management & Research Company LLC
14.62%
Decheng Capital LLC
7.45%
BlackRock Institutional Trust Company, N.A.
5.81%
Vanguard Capital Management, LLC
3.34%
其他
51.75%
持股股東
持股股東
佔比
Hung (David T)
17.02%
Fidelity Management & Research Company LLC
14.62%
Decheng Capital LLC
7.45%
BlackRock Institutional Trust Company, N.A.
5.81%
Vanguard Capital Management, LLC
3.34%
其他
51.75%
股東類型
持股股東
佔比
Investment Advisor
31.16%
Individual Investor
18.62%
Venture Capital
10.51%
Investment Advisor/Hedge Fund
9.28%
Hedge Fund
7.77%
Research Firm
2.03%
Bank and Trust
0.26%
Pension Fund
0.23%
Family Office
0.08%
其他
20.06%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
421
228.36M
65.58%
-32.85M
2025Q4
389
225.55M
65.98%
-37.34M
2025Q3
355
228.75M
66.72%
-24.74M
2025Q2
346
279.19M
82.03%
-27.71M
2025Q1
346
276.31M
81.30%
-31.14M
2024Q4
336
290.52M
86.58%
+4.56M
2024Q3
324
278.55M
83.07%
+36.83M
2024Q2
323
221.78M
89.68%
-2.09M
2024Q1
305
194.38M
89.06%
-41.04M
2023Q4
290
194.02M
89.00%
-35.90M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Hung (David T)
60.28M
17.39%
+500.00K
+0.84%
Jun 16, 2025
Fidelity Management & Research Company LLC
50.91M
14.69%
+854.51K
+1.71%
Dec 31, 2025
Decheng Capital LLC
25.95M
7.49%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
20.23M
5.84%
+250.74K
+1.26%
Dec 31, 2025
Omega Fund Management, LLC
8.08M
2.33%
-750.00K
-8.49%
Dec 31, 2025
Laurion Capital Management LP
7.85M
2.27%
-1.85M
-19.09%
Dec 31, 2025
State Street Investment Management (US)
5.86M
1.69%
-230.40K
-3.78%
Dec 31, 2025
Geode Capital Management, L.L.C.
5.71M
1.65%
-175.46K
-2.98%
Dec 31, 2025
Wang (Junyuan Jerry)
4.42M
1.27%
-56.36K
-1.26%
Nov 11, 2024
查看更多
持股ETF
更新時間: 12月2日 週二
更新時間: 12月2日 週二
機構名稱
佔比
State Street SPDR S&P Pharmaceuticals ETF
2.51%
Virtus LifeSci Biotech Clinical Trials ETF
1.95%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.79%
Tema Oncology ETF
1.66%
ALPS Medical Breakthroughs ETF
0.74%
iShares U.S. Pharmaceuticals ETF
0.46%
iShares Micro-Cap ETF
0.25%
iShares Health Innovation Active ETF
0.24%
Avantis US Small Cap Equity ETF
0.16%
iShares Biotechnology ETF
0.11%
查看更多
State Street SPDR S&P Pharmaceuticals ETF
佔比2.51%
Virtus LifeSci Biotech Clinical Trials ETF
佔比1.95%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比1.79%
Tema Oncology ETF
佔比1.66%
ALPS Medical Breakthroughs ETF
佔比0.74%
iShares U.S. Pharmaceuticals ETF
佔比0.46%
iShares Micro-Cap ETF
佔比0.25%
iShares Health Innovation Active ETF
佔比0.24%
Avantis US Small Cap Equity ETF
佔比0.16%
iShares Biotechnology ETF
佔比0.11%